Stephen M Kimani1, Melissa H Watt1, M Giovanna Merli2, Donald Skinner3, Bronwyn Myers4, Desiree Pieterse3, Jessica C MacFarlane1, Christina S Meade5. 1. Duke University, Duke Global Health Institute, Box 90519, Durham, NC 27708, USA. 2. Duke University, Duke Global Health Institute, Box 90519, Durham, NC 27708, USA; Duke University, Sanford School of Public Policy, Box 90311, Durham, NC 27708, USA. 3. Stellenbosch University, Faculty of Health Sciences, Box 19063, Tygerberg 7505, South Africa. 4. Department of Psychiatry and Mental Health, University of Cape Town, Anzio Road, Observatory, South Africa. 5. Duke University, Duke Global Health Institute, Box 90519, Durham, NC 27708, USA; Duke University School of Medicine, Department of Psychiatry & Behavioral Sciences, Durham, NC 27708, USA. Electronic address: christina.meade@duke.edu.
Abstract
BACKGROUND: South Africa, in the midst of the world's largest HIV epidemic, has a growing methamphetamine problem. Respondent driven sampling (RDS) is a useful tool for recruiting hard-to-reach populations in HIV prevention research, but its use with methamphetamine smokers in South Africa has not been described. This study examined the effectiveness of RDS as a method for engaging methamphetamine users in a Cape Town township into HIV behavioral research. METHODS: Standard RDS procedures were used to recruit active methamphetamine smokers from a racially diverse peri-urban township in Cape Town. Effectiveness of RDS was determined by examining social network characteristics (network size, homophily, and equilibrium) of recruited participants. RESULTS: Beginning with eight seeds, 345 methamphetamine users were enrolled over 6 months, with a coupon return rate of 67%. The sample included 197 men and 148 women who were racially diverse (73% Coloured, 27% Black African) and had a mean age of 28.8 years (SD=7.2). Social networks were adequate (mean network size >5) and mainly comprised of close social ties. Equilibrium on race was reached after 11 waves of recruitment, and after ≤3 waves for all other variables of interest. There was little to moderate preference for either in- or out-group recruiting in all subgroups. CONCLUSIONS: Results suggest that RDS is an effective method for engaging methamphetamine users into HIV prevention research in South Africa. Additionally, RDS may be a useful strategy for seeking high-risk methamphetamine users for HIV testing and linkage to HIV care in this and other low resource settings.
BACKGROUND: South Africa, in the midst of the world's largest HIV epidemic, has a growing methamphetamine problem. Respondent driven sampling (RDS) is a useful tool for recruiting hard-to-reach populations in HIV prevention research, but its use with methamphetamine smokers in South Africa has not been described. This study examined the effectiveness of RDS as a method for engaging methamphetamine users in a Cape Town township into HIV behavioral research. METHODS: Standard RDS procedures were used to recruit active methamphetamine smokers from a racially diverse peri-urban township in Cape Town. Effectiveness of RDS was determined by examining social network characteristics (network size, homophily, and equilibrium) of recruited participants. RESULTS: Beginning with eight seeds, 345 methamphetamine users were enrolled over 6 months, with a coupon return rate of 67%. The sample included 197 men and 148 women who were racially diverse (73% Coloured, 27% Black African) and had a mean age of 28.8 years (SD=7.2). Social networks were adequate (mean network size >5) and mainly comprised of close social ties. Equilibrium on race was reached after 11 waves of recruitment, and after ≤3 waves for all other variables of interest. There was little to moderate preference for either in- or out-group recruiting in all subgroups. CONCLUSIONS: Results suggest that RDS is an effective method for engaging methamphetamine users into HIV prevention research in South Africa. Additionally, RDS may be a useful strategy for seeking high-risk methamphetamine users for HIV testing and linkage to HIV care in this and other low resource settings.
Authors: Jichuan Wang; Robert G Carlson; Russel S Falck; Harvey A Siegal; Ahmmed Rahman; Linna Li Journal: Drug Alcohol Depend Date: 2004-12-22 Impact factor: 4.492
Authors: Nora D Volkow; Gene-Jack Wang; Joanna S Fowler; Frank Telang; Millard Jayne; Christopher Wong Journal: Am J Psychiatry Date: 2007-01 Impact factor: 18.112
Authors: Peter Freeman; Bendu C Walker; D Robert Harris; Robert Garofalo; Nancy Willard; Jonathan M Ellen Journal: Arch Pediatr Adolesc Med Date: 2011-08
Authors: Louisa Degenhardt; Bradley Mathers; Mauro Guarinieri; Samiran Panda; Benjamin Phillips; Steffanie A Strathdee; Mark Tyndall; Lucas Wiessing; Alex Wodak; John Howard Journal: Int J Drug Policy Date: 2010-02-01
Authors: Steve Shoptaw; Brooke Montgomery; Chyvette T Williams; Nabila El-Bassel; Apinun Aramrattana; Lisa Metsch; David S Metzger; Irene Kuo; Francisco I Bastos; Steffanie A Strathdee Journal: J Acquir Immune Defic Syndr Date: 2013-07 Impact factor: 3.731
Authors: Lucy Platt; Martin Wall; Tim Rhodes; Ali Judd; Matthew Hickman; Lisa G Johnston; Adrian Renton; Natalia Bobrova; Anya Sarang Journal: J Urban Health Date: 2006-11 Impact factor: 3.671
Authors: Christina S Meade; Sheri L Towe; Melissa H Watt; Ryan R Lion; Bronwyn Myers; Donald Skinner; Stephen Kimani; Desiree Pieterse Journal: Drug Alcohol Depend Date: 2015-04-30 Impact factor: 4.492
Authors: Nora E Rosenberg; Christopher C Stanley; Sarah E Rutstein; Naomi Bonongwe; Gift Kamanga; Audrey Pettifor; Clement Mapanje; Francis Martinson; Irving F Hoffman; William C Miller Journal: Sex Transm Infect Date: 2016-05-13 Impact factor: 3.519
Authors: Andréa L Hobkirk; Melissa H Watt; Kimberly T Green; Jean C Beckham; Donald Skinner; Christina S Meade Journal: Addict Behav Date: 2014-11-26 Impact factor: 3.913
Authors: Tara Carney; Jennifer A Rooney; Nandi Niemand; Bronwyn Myers; Danie Theron; Robin Wood; Laura F White; Christina S Meade; Novel N Chegou; Elizabeth Ragan; Gerhard Walzl; Robert Horsburgh; Robin M Warren; Karen R Jacobson Journal: PLoS One Date: 2022-02-15 Impact factor: 3.752
Authors: Caitlin Gerdts; Sarah Raifman; Kristen Daskilewicz; Mariette Momberg; Sarah Roberts; Jane Harries Journal: BMC Womens Health Date: 2017-10-02 Impact factor: 2.809